← All indications
Gender Dysphoria
A marked difference between the individual’s expressed/experienced gender and the gender others would assign to the individual, and it must continue for at least six months. (from DSM-5)
Drugs by status
Approved for this indication (1)
Phase 4 trials (8)
Phase 3 trials (4)
Phase 1 trials (4)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (1)